Association between Nutrient Intakes and Benign Prostate Hyperplasia

영양소 섭취와 전립선비대증과의 연관성 연구

  • 박혜숙 (이화여자대학교 의과대학 예방의학교실) ;
  • 장남수 (이화여자대학교 생활환경대학 식품영양학과) ;
  • 김은정 (이화여자대학교 생활환경대학 식품영양학과) ;
  • 윤하나 (이화여자대학교 의과대학 비뇨기과학교실) ;
  • 이훈재 (인하대학교 의과대학 사회의학교실) ;
  • 이보은 (이화여자대학교 의과대학 예방의학교실) ;
  • 김한해 (서울대보건대학원 보건정책) ;
  • 권성원 (이화여자대학교 의과대학 비뇨기과학교실) ;
  • 정유진 (양천구보건소)
  • Published : 2004.11.01

Abstract

Benign prostatic hyperplasia (BPH) is the most common prostate disease in middle aged and elderly men. Therefore, identifying risk factors for BPH is crucial for understanding the etiology and for undertaking interventions or targeting strategies. The survey was carried out in two steps: first, pilot study was conducted prior to the main study in order to estimate baseline characteristics. Second, main study investigated prevalence and risk factors of BPH by clinical diagnostic tests and questionnaire. A total of 641 male aged 50-79 years participated in this community-based cross-sectional study. Using 24 hour recall of food consumption, we found that animal fat intakes increased the risk of BPH with adjusted for age, chronic bronchitis, PSA level, drinking frequency, and excercise frequency (odds ratio 1.84,95% confidence interval 1.10-3.06) . Although BPH has been considered as unavoidable disease with advancing age, if these dietary risk factors are clearly identified, it can be prevented effectively by laying special emphasis on those at risk.

Keywords

References

  1. Apolone G, Cattaneo A, Colombo P, La Vecchia C, Cavazzuti L, Bamfi F. Knowledge and opinion on prostate and prevalence of self-reported BPH and prostate-related events. A cross-sectional survey in Italy. Eur J Cancer Prey 11 (5) : 473-479, 2002 https://doi.org/10.1097/00008469-200210000-00010
  2. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 150 (1) : 85-89, 1993
  3. Norman RW, Nickel JC, Fish D, Pickett SN. 'Prostate-related symptoms' in Canadian men 50 years of age or older: prevalence and relationships among symptoms. Br J UroI 74 (5) : 542-550, 1994 https://doi.org/10.1111/j.1464-410X.1994.tb09181.x
  4. Tsukamoto T, Kumamoto Y, Masumori N, Miyake H, Rhodes T, Girman CJ, Guess HA, Jacobsen SJ, Lieber MM. Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol 154 (2 Pt 1) : 391-395, 1995
  5. Hunter DJ, Berra-Unamuno A, Martin-Gordo A. Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older. J Urol 155 (6): 1965-1970, 1996 https://doi.org/10.1016/S0022-5347(01)66063-4
  6. Engstrom G, Walker-Engstrom ML, Loof L, Leppert J. Prevalence of three lower urinary tract symptoms in men-a population-based study. Fam Pract 20 (1) : 7-10, 2003 https://doi.org/10.1093/fampra/20.1.7
  7. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet. 1991 Aug 24; 338 (8765) : 469-471. Gass R. Benign prostate hyperplasia: the opposite effects of alcohol and coffee intake. BJU International 90: 649-654, 2002 https://doi.org/10.1046/j.1464-410X.2002.03001.x
  8. Bosch JL, Hop WC, Kirkels WJ, Schroder FH. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 75 (5) : 622-630, 1995 https://doi.org/10.1111/j.1464-410X.1995.tb07421.x
  9. Chicharro-Molero JA, Burgos-Rodriguez R, Sanchez-Cruz JJ, del Rosal-Samaniego JM, Rodero-Carcia P, Rodriguez-Vallejo JM. Prevalence of benign prostatic hyperplasia in Spanish men 40 years old or older. J Urol 159 (3) : 878-882, 1998 https://doi.org/10.1016/S0022-5347(01)63760-1
  10. Blanker MH, Groeneveld FP, Prins A, Bernsen RM, Bohnen AM, Bosch JL. Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital trat problens and general health status. BJU Int 85 (6) : 665-671, 2000 https://doi.org/10.1046/j.1464-410x.2000.00570.x
  11. Choi J, Ikeguchi EF, Lee SW, Choi HY, Te AE, Kaplan SA. Is the higher prevalence of benign prostatic hyperplasia related to lower urinary tract symptoms in Korean men due to a high transition zone index? Eur Urol 42 (1) : 7-11, 2002 https://doi.org/10.1016/S0302-2838(02)00222-1
  12. Lee ES, Lee C, Kim Y, Shin Y. Estimation of benign prostatic hyperplasia prevalence in Korea: An epidemiological survey using International Prostatic Symptom Score (IPSS) in Yonchon county. Korean J Urol 36 (12) : 1345-1352, 1995
  13. Cho BM, Lee SD, Chung MK. The lifestyle factors in relation to benign prostatic hyperplasia in a rural community. Korean J Urol 40 (5) : 589-593, 1999
  14. Cho KS. Prevalemce of lower urinary tract symptoms (LUTS) in Korean elderly men: Epidemiologic survey using International Prostatic Symptom Score (I-PSS). Graduate School of Seoul University, Thesis of Master of Science, 2000
  15. Cho KS, Jo MK, Lim D, Son H, Park SK, Yoo KY, Kim HH, Lee C. Epidemiologic survey using International Prostate Symptom Score (I-PSS) of lowe urinary tract symptoms (LUTS) in elderly men above 40 years old in Seoul area. Korean J Urol 42 (8) : 840-848, 2001
  16. Coffey DS, Walsh PC. Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 17: 461-475, 1990
  17. Tan MO, Karabiyik I, Uygur MC, Diker Y, Erol D. Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia. Int Urol Nephrol 35 (3) : 357-363, 2003 https://doi.org/10.1023/B:UROL.0000022909.57112.3e
  18. Boyle P, McGinn R, Maisonneuve P, La Vecchia C. Epidemiology of benign prostatic hyperplasia: Present knowledge and studies needed. Eur Urol 20 (I SuppI): 3-10, 1991
  19. Lee E, Park M-S, Shin C, Lee H, Yoo K, Kim Y, Shin Y, Paik H-Y, Lee C. A high-risk group for prostatism: a population-based epidemiological study in Korea. Br J Urol 79: 736-741, 1997 https://doi.org/10.1046/j.1464-410X.1997.00149.x
  20. Platz EA, Rimm EB, Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Ginovannucci E. Alcohol consumption, cigarette smoking, and risk of benign prostate hyperplasia. Am J Epidemiol 149: 106-115, 1999 https://doi.org/10.1093/oxfordjournals.aje.a009775
  21. Koskimaki J, Hakama M, Huhtala H, Tammela TLJ. Association of dietary elements and lower urinary tract symptoms. Scand J Urol Nephrol 34: 46-50, 2000 https://doi.org/10.1080/003655900750016887
  22. Meigs JB, Mojr B, Barry MJ, Collins MM, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54: 935-944, 2001 https://doi.org/10.1016/S0895-4356(01)00351-1
  23. Suzuki S, Platz EA, Kawachi I, Willett WC, Giovanntcci E. Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr 75: 689-697, 2002
  24. Gass R. Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake. BJU Int 90 (7) : 649-654, 2002 https://doi.org/10.1046/j.1464-410X.2002.03001.x
  25. Dahle SE, Chokkalingam AP, Gao Y-T, Deng J, Stanczyk FZ, Hsing AW. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. The Journal of Urology 168: 599-604, 2002 https://doi.org/10.1016/S0022-5347(05)64687-3
  26. Joseph MA, Harlow SD, Wei JT, Sarma AV, Dunn RL, Taylor JMG, James SA, Cooney KA, Doerr KM, Montie JE, Schottenfeld D. Risk factors for lower urinary tract symptoms in a population-based sample of African-American Men. Am J Epidemiol 157: 906-914. 2003 https://doi.org/10.1093/aje/kwg051
  27. Kliewer EV. Benign prostatic hyperplasia morbidity and mortality among immigrants in Australia and Canada. Prostate 28: 211-218, 1996 https://doi.org/10.1002/(SICI)1097-0045(199604)28:4<211::AID-PROS1>3.0.CO;2-G
  28. Lagiou P, Wuu J, Trichopoulou A, Hsieh CC, Adami HO, Trichopoulos D. Diet and benign prostatic hyperplasia: A study in Greece. Urology 54: 284-290, 1999 https://doi.org/10.1016/S0090-4295(99)00096-5
  29. Koskimaki J, Hakama M, Huhtala H, Tammela TLJ. Association of dietary elements and lower urinary tract symptoms. Scand J Urol Nephrol 34: 46-50, 2000 https://doi.org/10.1080/003655900750016887
  30. Ning X, Shi JP, Wu ZY, Zheng LG, Wang HL. A case-control study on the risk factors of benign prostate hyperplasia in th suburb of Shenyang. Zhonghua Liu Xing Bing Xue Za Zhi 24: 276-80, 2003
  31. The Korean Nutrition Society. Can-Pro version 2.0, 2003
  32. Kim H-G, Park JY, lung SM, Lee SH, Lee SY. Benign prostatic hyperplasia: Its feature and impact on the quality of life in rural area of Kangwon province. Koean J Urol 40 (4) : 446-452, 1999
  33. Chyou PH, Nomura AMY, Stemmermann GN, Hankin JH. A prospective study of alcohol, diet, and other lifestyle factors in relation to obstructive uropathy. Prostate 22: 253-264, 1993 https://doi.org/10.1002/pros.2990220308
  34. Araki H, Watanabe H, Mishina T, Nakao M. High-risk group for benign prostatic hypertrophy. Prostate 4: 253-264, 1983 https://doi.org/10.1002/pros.2990040305
  35. Fitzpatrick JM, Lynch TH. Phytotherapeutic agents. In: Kirby R, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P, editors. Textbook of benign prostatic hyperplasia. Oxford: ISIS Medical Media, pp.331-337, 1996
  36. Glick M, Michel AC, Dorn J, Horwitz M, Rosenthal T, Trevisan M. Dietary cardiovascular risk factors and serum cholesterol in an Old Order Mennonite community. Am J Public Health 88: 1202-1205, 1998 https://doi.org/10.2105/AJPH.88.8.1202
  37. Gu F. Changes in the prevalence of benign prostatic hyperplasia in China. Chin Med J (Engl) 110 (3) : 163-166, 1997
  38. Graves EJ, Gillium BS. Detailed diagnoses and procedures. National Hospital Disease Survey, 1994. Vital Health Stat 13 130: 1-146, 1997
  39. Fitzpatrick JM, Lynch TH. Phytotherapeutic agents in the management of symptomatic benign prostatic hyperplasia. Urol Clin N Am 22: 407-412, 1995
  40. Wiza A, Lisette G, Ybel B, Reggy W. Assessing diets of elderly people: problem and approaches. Am J Clin Nutr 59 (suppI) : 221-223, 1994